Literature DB >> 20932506

Focus on cystic fibrosis and other disorders evidenced in fetuses with sonographic finding of echogenic bowel: 16-year report from Brittany, France.

Virginie Scotet1, Ingrid Duguépéroux, Marie-Pierre Audrézet, Séverine Audebert-Bellanger, Matthieu Muller, Martine Blayau, Claude Férec.   

Abstract

OBJECTIVE: Pregnancies medical follow-up and ultrasonography development have enabled detection of fetal echogenic bowel, a sign associated with various pathologies, including cystic fibrosis. Based on the long experience of a region where cystic fibrosis is frequent (Brittany, France), we describe disorders diagnosed in fetal echogenic bowel fetuses and assess ultrasonography ability in detecting cystic fibrosis in utero. STUDY
DESIGN: We reviewed the cases of fetal echogenic bowel diagnosed in pregnant women living in Brittany and referred for CFTR gene analysis over the 1992-2007 period (n = 289).
RESULTS: A disorder was diagnosed in 32.2% of the fetuses, cystic fibrosis being the most commonly identified (7.6%). We also found digestive malformations (7.0%), chromosomal abnormalities (3.7%), and maternofetal infections (3.7%). Combining these data with our ongoing newborn screening program since 1989 showed that ultrasonography enabled diagnosis of 10.7% of the cystic fibrosis cases.
CONCLUSION: This study highlights the importance of pregnancy ultrasound examinations and their efficiency in detecting cystic fibrosis.
Copyright © 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20932506     DOI: 10.1016/j.ajog.2010.08.033

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

Review 1.  Beyond pancreatic insufficiency and liver disease in cystic fibrosis.

Authors:  Stephanie Demeyer; Kris De Boeck; Peter Witters; Katrien Cosaert
Journal:  Eur J Pediatr       Date:  2016-04-07       Impact factor: 3.183

2.  Echogenic bowel on second-trimester ultrasonography: evaluating the risk of adverse pregnancy outcome.

Authors:  Katherine R Goetzinger; Alison G Cahill; George A Macones; Anthony O Odibo
Journal:  Obstet Gynecol       Date:  2011-06       Impact factor: 7.661

3.  Coexistence of meconium ileus with duodenal atresia and trisomy 21 in a newborn: a case report.

Authors:  O W Akinloye; W Truong; M Giacomantonio; D Mateos; W El-Naggar
Journal:  J Perinatol       Date:  2014-11       Impact factor: 2.521

Review 4.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

5.  Computed Tomography (CT) Scanning Facilitates Early Identification of Neonatal Cystic Fibrosis Piglets.

Authors:  Antoine Guillon; Claire Chevaleyre; Celine Barc; Mustapha Berri; Hans Adriaensen; François Lecompte; Thierry Villemagne; Jérémy Pezant; Rémi Delaunay; Joseph Moënne-Loccoz; Patricia Berthon; Andrea Bähr; Eckhard Wolf; Nikolai Klymiuk; Sylvie Attucci; Reuben Ramphal; Pierre Sarradin; Dominique Buzoni-Gatel; Mustapha Si-Tahar; Ignacio Caballero
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.